The CLCA gene family: Putative therapeutic target for respiratory diseases

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 2, 2009, Pages 146-160

  Winpenny, John P ^a   Marsey, Laura L ^a   Sexton, Darren W ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Asthma; Chloride channel calcium activated; CLCA gene family; COPD; Cystic fibrosis; Inflammation

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; CHLORIDE CHANNEL; CHLORIDE CHANNEL CALCIUM ACTIVATED 1 PROTEIN; CHLORIDE CHANNEL CALCIUM ACTIVATED 2 PROTEIN; CHLORIDE CHANNEL CALCIUM ACTIVATED 3 PROTEIN; CHLORIDE CHANNEL CALCIUM ACTIVATED 4 PROTEIN; CORTICOSTEROID; INTERLEUKIN 13; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; MSI 2216; MUCIN 5AC; NIFLUMIC ACID; STAT6 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL GENETICS; APOPTOSIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DRUG TARGETING; GENE LOCATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; HUMAN; HUMAN GENETICS; METASTASIS; MOLECULAR CLONING; MUCUS SECRETION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS;

ANIMALS; APOPTOSIS; ASTHMA; BODILY SECRETIONS; CALCIUM; CELL ADHESION; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CHLORIDE CHANNELS; CYSTIC FIBROSIS; EPITHELIAL CELLS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 70349492400     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809788462590     Document Type: Review

References (96)

1. Jentsch, T.J.; Stein, V.; Weinreich, F.; Zdebik, A.A. Molecular structure and physiological function of chloride channels. Physiol. Rev., 2002, 82, 503-68.
2. Sheppard, D.N.; Welsh, M.J. Structure and function of the CFTR chloride channel. Physiol. Rev., 1999, 79, (Suppl 1), S23-45.
3. Nilius, B.; Droogmans, G., Amazing chloride channnels: an overview. Acta Physiol. Scand., 2003, 177, 119-47.
4. Jentsch, T.J.; Neagoe, I.; Scheel, O. CLC chloride channels and transporters. Curr. Opin. Neurobiol., 2005, 15, 319-25.
5. Hartzell, C.; Putzier, I.; Arreola, J. Calcium-activated chloride channels. Annu. Rev. Physiol., 2005, 67, 719-58.
6. Eggermont, J. Calcium-activated chloride channels: (un)known, (un)loved? Proc. Am. Thorac. Soc., 2004, 1, 22-7.
7. Cunningham, S.A.; Awayda, M.S.; Bubien, J.K.; Ismailov, I.; Arrate, M.P.; Berdiev, B.K.; Benos, D.J.; Fuller, C.M. Cloning of an epithelial chloride channel from bovine trachea. J. Biol. Chem., 1995, 270, 31016-26.
8. Loewen, M.E.; Forsyth, G.W. Structure and function of CLCA proteins. Physiol. Rev., 2005, 85, 1061-92.
9. Gibson, A.; Lewis, A.P.; Affleck, K.; Aitken, A.J.; Meldrum, E.; Thompson, N. hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels. J. Biol. Chem., 2005, 280, 27205-12.
10. Elble, R.C.; Walia, V.; Cheng, H. C.; Connon, C.J.; Mundhenk, L.; Gruber, A.D.; Pauli, B.U., The putative chloride channel hCLCA2 has a single C-terminal transmembrane segment. J. Biol. Chem., 2006, 281, 29448-54.
11. Mundhenk, L.; Alfalah, M.; Elble, R.C.; Pauli, B.U.; Naim, H.Y.; Gruber, A.D. Both cleavage products of the mCLCA3 protein are secreted soluble proteins. J. Biol. Chem., 2006, 281, 30072-80.
12. Bustin, S.A.; Li, S.R.; Dorudi, S. Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer. DNA Cell Biol., 2001, 20, 331-8.
13. Abdel-Ghany, M.; Cheng, H.C.; Elble, R.C.; Lin, H.; DiBiasio, J.; Pauli, B.U. The interacting binding domains of the beta(4) integrin and calcium-activated chloride channels (CLCAs) in metastasis. J. Biol. Chem., 2003, 278, 49406-16.
14. Abdel-Ghany, M.; Cheng, H.C.; Elble, R.C.; Pauli, B.U. The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis. J. Biol. Chem., 2001, 276, 25438-46.
15. Ran, S.; Benos, D.J. Immunopurification and structural analysis of a putative epithelial Cl- channel protein isolated from bovine trachea. J. Biol. Chem., 1992, 267, 3618-25.
16. Ran, S.; Fuller, C.M.; Arrate, M.P.; Latorre, R.; Benos, D.J. Functional reconstitution of a chloride channel protein from bovine trachea. J. Biol. Chem., 1992, 267, 20630-7.
17. Agnel, M.; Vermat, T.; Culouscou, J. Identification of three novel members of the calcium-dependent chloride channel (CaCC) family predominantly expressed in the digestive tract and trachea. FEBS lett., 1999, 455, 295-301.
18. Elble, R.C.; Widom, J.; Gruber, A.D.; Abdel-Ghany, M.; Levine, R.; Goodwin, A.; Cheng, H.C.; Pauli, B.U. Cloning and characterization of lung-endothelial cell adhesion molecule-1 suggest it is an endothelial chloride channel. J. Biol. Chem., 1997, 272, 27853-61.
19. - channel proteins. Genomics, 1998, 54, 200-14.
20. Gruber, A.D.; Schreur, K.D.; Ji, H.; Fuller, C.M.; Pauli, B.U. Molecular cloning and transmembrane structure if hCLCA2 from human lung, trachea and mammary gland. Am. J. Cell Physiol., 1999, 276 (Cell Physiol. 45), C1261-C70.
21. Gruber, A.D.; Pauli, B.U. Molecular cloning and biochemical characterization of a truncated, secreted member of the human family of Ca2+-activated Cl- channels. Biochim. Biophys. Acta, 1999, 1444, 418-23.
22. Gandhi, R.; Elble, R.C.; Gruber, A.D.; Schreur, K.D.; Ji, H.L.; Fuller, C.M.; Pauli, B.U. Molecular and functional characterization of a calcium-sensitive chloride channel from mouse lung. J. Biol. Chem., 1998, 273, 32096-101.
23. 2+-sensitive chloride channel 2 gene during involution of mammary gland. Biochem. Biophys. Res. Commun., 1999, 264, 933-7.
24. Komiya, T.; Tanigawa, Y.; Hirohashi, S. Cloning and identification of the gene Gob-5, which is expressed in intestinal goblet cells in mice. Biochem. Biophys. Res. Commun., 1999, 255, 347-351.
25. Elble, R.C.; Ji, G.; Nehrke, K.; DeBiasio, J.; Kingsley, P.D.; Kotlikoff, M.I.; Pauli, B.U. Molecular and functional characterization of a murine calcium-activated chloride channel expressed in smooth muscle. J. Biol. Chem., 2002, 277, 18586-91.
26. Evans, S.R.; Thoreson, W.B.; Beck, C.L. Molecular and functional analyses of two new calcium-activated chloride channel family members from mouse eye and intestine. J. Biol. Chem., 2004, 279, 41792-800.
27. Bothe, M.K.; Braun, J.; Mundhenk, L.; Gruber, A.D. Murine mCLCA6 is an integral apical membrane protein of non-goblet cell enterocytes and co-localizes with the cystic fibrosis transmembrane conductance regulator. J. Histochem. Cytochem., 2008, 56, 495-509.
28. Leverkoehne, I.; Holle, H.; Anton, F.; Gruber, A.D. Differential expression of calcium-activated chloride channels (CLCA) gene family members in the small intestine of cystic fibrosis mouse models. Histochem. Cell Biol., 2006, 126, 239-50.
29. Leverkoehne, I.; Gruber, A.D. The murine mCLCA3 (alias gob-5) protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J. Histochem. Cytochem., 2002, 50, 829-38.
30. Romio, L.; Musante, L.; Cinti, R.; Seri, M.; Moran, O.; Zegarra-Moran, O.; Galietta, L.J. Characterization of a murine gene homologous to the bovine CaCC chloride channel. Gene, 1999, 228, 81-8.
31. Gaspar, K.J.; Racette, K.J.; Gordon, J.R.; Loewen, M.E.; Forsyth, G.W. Cloning a chloride conductance mediator from the apical membrane of porcine ileal enterocytes. Physiol. Genom., 2000, 3, 101-11.
32. Zhu, D.Z.; Cheng, C.F.; Pauli, B.U. Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc. Natl. Acad. Sci. USA, 1991, 88, 9568-72.
33. Zhu, D.; Cheng, C.F.; Pauli, B.U. Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis. J. Clin. Invest., 1992, 89, 1718-24.
34. Connon, C.J.; Yamasaki, K.; Kawasaki, S.; Quantock, A.J.; Koizumi, N.; Kinoshita, S. Calcium-activated chloride channel-2 in human epithelia. J. Histochem. Cytochem., 2004, 52, 415-8.
35. Connon, C.J.; Kawasaki, S.; Yamasaki, K.; Quantock, A.J.; Kinoshita, S. The quantification of hCLCA2 and colocalisation with integrin beta4 in stratified human epithelia. Acta Histochem., 2005, 106, 421-5.
36. Abdel-Ghany, M.; Cheng, H.C.; Elble, R.C.; Pauli, B.U., Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J. Biol. Chem., 2002, 277, 34391-400.
37. 2+-activated chloride channel CLCA2. Cancer Res., 1999, 59, 5488-91.
38. Beckley, J.R.; Pauli, B.U.; Elble, R.C. Re-expression of detachment-inducible chloride channel mCLCA5 suppresses growth of metastatic breast cancer cells. J. Biol. Chem., 2004, 279, 41634-41.
39. Elble, R.C.; Pauli, B.U. Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J. Biol. Chem., 2001, 276, 40510-7.
40. Loewen, M.E.; Bekar, L.K.; Gabriel, S.E.; Walz, W.; Forsyth, G.W. pCLCA1 becomes a cAMP-dependent chloride conductance mediator in Caco-2 cells. Biochem. Biophys. Res. Commun., 2002, 298, 531-6.
41. Loewen, M.E.; Bekar, L.K.; Walz, W.; Forsyth, G.W.; Gabriel, S.E. pCLCA1 lacks inherent chloride channel activity in an epithelial colon carcinoma cell line. Am. J. Physiol. Gastrointest. Liver Physiol., 2004, 287, G33-41.
42. Loewen, M.E.; Gabriel, S.E.; Forsyth, G.W. The calcium-dependent chloride conductance mediator pCLCA1. Am. J. Physiol. Cell Physiol., 2002, 283, C412-21.
43. Busse, W.W.; Lemanske, R.F., Jr. Asthma. N. Engl. J. Med., 2001, 344, 350-62.
44. Hayday, A.; Viney, J.L. The ins and outs of body surface immunology. Science, 2000, 290, 97-100.
45. Walsh, G.M.; Sexton, D.W.; Blaylock, M.G. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J. Endocrinol., 2003, 178, 37-43.
46. Holgate, S.T. The airway epithelium is central to the pathogenesis of asthma. Allergol. Int., 2008, 57, 1-10.
47. Stick, S.M.; Holt, P.G. The airway epithelium as immune modulator: the LARC ascending. Am. J. Respir. Cell Mol. Biol., 2003, 28, 641-4.
48. Nakanishi, A.; Morita, S.; Iwashita, H.; Sagiya, Y.; Ashida, Y.; Shirafuji, H.; Fujisawa, Y.; Nishimura, O.; Fujino, M., Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc. Natl. Acad. Sci. USA, 2001, 98, 5175-80.
49. Zhou, Y.; Dong, Q.; Louahed, J.; Dragwa, C.; Savio, D.; Huang, M.; Weiss, C.; Tomer, Y.; McLane, M.P.; Nicolaides, N.C.; Levitt, R.C. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am. J. Respir. Cell Mol. Biol., 2001, 25, 486-91.
50. Hoshino, M.; Morita, S.; Iwashita, H.; Sagiya, Y.; Nagi, T.; Nakanishi, A.; Ashida, Y.; Nishimura, O.; Fujisawa, Y.; Fujino, M. Increased expression of the human Ca2+-activated Cl- channel 1 (CaCC1) gene in the asthmatic airway. Am. J. Respir. Crit. Care Med., 2002, 165, 1132-6.
51. Toda, M.; Tulic, M.K.; Levitt, R.C.; Hamid, Q. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J. Allergy Clin. Immunol., 2002, 109, 246-50.
52. Wang, K.; Wen, F.Q.; Feng, Y.L.; Ou, X.M.; Xu, D.; Yang, J.; Deng, Z.P., Increased expression of human calcium-activated chloride channel 1 gene is correlated with mucus overproduction in Chinese asthmatic airway. Cell Biol. Int., 2007, 31, 1388-95.
53. Galietta, L.J.; Folli, C.; Marchetti, C.; Romano, L.; Carpani, D.; Conese, M.; Zegarra-Moran, O. Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma. Am. J. Physiol. Lung Cell Mol. Physiol., 2000, 278, L1186-94.
54. Atherton, H.; Mesher, J.; Poll, C.T.; Danahay, H. Preliminary pharmacological characterisation of an interleukin-13-enhanced calcium-activated chloride conductance in the human airway epithelium. Naunyn. Schmiedebergs Arch. Pharmacol., 2003, 367, 214-7.
55. Danahay, H.; Atherton, H.; Jones, G.; Bridges, R.J.; Poll, C.T. Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol., 2002, 282, L226-36.
56. Galietta, L.J.; Pagesy, P.; Folli, C.; Caci, E.; Romio, L.; Costes, B.; Nicolis, E.; Cabrini, G.; Goossens, M.; Ravazzolo, R.; Zegarra-Moran, O. IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J. Immunol., 2002, 168, 839-45.
57. Kuperman, D.A.; Huang, X.; Koth, L.L.; Chang, G.H.; Dolganov, G.M.; Zhu, Z.; Elias, J.A.; Sheppard, D.; Erle, D.J. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med., 2002, 8, 885-9.
58. Thai, P.; Chen, Y.; Dolganov, G.; Wu, R. Differential regulation of MUC5AC/Muc5ac and hCLCA-1/mGob-5 expression in airway epithelium. Am. J. Respir. Cell Mol. Biol., 2005, 33, 523-30.
59. Atherton, H.C.; Jones, G.; Danahay, H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am. J. Physiol. Lung Cell Mol. Physiol., 2003, 285, L730-9.
60. Long, A.J.; Sypek, J.P.; Askew, R.; Fish, S.C.; Mason, L.E.; Williams, C.M.; Goldman, S.J. Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation. Am. J. Respir. Cell Mol. Biol., 2006, 35, 357-65.
61. Robichaud, A.; Tuck, S.A.; Kargman, S.; Tam, J.; Wong, E.; Abramovitz, M.; Mortimer, J.R.; Burston, H.E.; Masson, P.; Hirota, J.; Slipetz, D.; Kennedy, B.; O'Neill, G.; Xanthoudakis, S. Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthma. Am. J. Respir. Cell Mol. Biol., 2005, 33, 303-14.
62. Patel, A.C.; Morton, J.D.; Kim, E.Y.; Alevy, Y.; Swanson, S.; Tucker, J.; Huang, G.; Agapov, E.; Phillips, T.E.; Fuentes, M.E.; Iglesias, A.; Aud, D.; Allard, J. D.; Dabbagh, K.; Peltz, G.; Holtzman, M.J. Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members. Physiol. Genom., 2006, 25, 502-13.
63. Yasuo, M.; Fujimoto, K.; Tanabe, T.; Yaegashi, H.; Tsushima, K.; Takasuna, K.; Koike, T.; Yamaya, M.; Nikaido, T. Relationship between calcium-activated chloride channel 1 and MUC5AC in goblet cell hyperplasia induced by interleukin-13 in human bronchial epithelial cells. Respiration, 2006, 73, 347-59.
64. Ciencewicki, J.; Trivedi, S.; Kleeberger, S.R. Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol., 2008, 122, 456-68.
65. Dharajiya, N.; Choudhury, B.K.; Bacsi, A.; Boldogh, I.; Alam, R.; Sur, S. Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase-induced signal by intrapulmonary administration of antioxidants blocks allergic airway inflammation. J. Allergy Clin. Immunol., 2007, 119, 646-53.
66. Reynaert, N.L.; Aesif, S.W.; McGovern, T.; Brown, A.; Wouters, E.F.; Irvin, C. G.; Janssen-Heininger, Y.M. Catalase overexpression fails to attenuate allergic airways disease in the mouse. J. Immunol., 2007, 178, 3814-21.
67. Hegab, A.E.; Sakamoto, T.; Uchida, Y.; Nomura, A.; Ishii, Y.; Morishima, Y.; Mochizuki, M.; Kimura, T.; Saitoh, W.; Massoud, H.H.; Massoud, H.M.; Hassanein, K. M.; Sekizawa, K. CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J. Med. Genet., 2004, 41, e27.
68. Hauber, H.P.; Bergeron, C.; Tsicopoulos, A.; Wallaert, B.; Olivenstein, R.; Holroyd, K.J.; Levitt, R.C.; Hamid, Q. Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis. Can. Respir. J., 2005, 12, 143-6.
69. Hegab, A.E.; Sakamoto, T.; Nomura, A.; Ishii, Y.; Morishima, Y.; Iizuka, T.; Kiwamoto, T.; Matsuno, Y.; Homma, S.; Sekizawa, K. Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. Chest, 2007, 131, 1149-56.
70. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy, 1994, 49, (Suppl 19), 1-34.
71. Bousquet, J.; Reid, J.; van Weel, C.; Baena Cagnani, C.; Canonica, G.W.; Demoly, P.; Denburg, J.; Fokkens, W.J.; Grouse, L.; Mullol, K.; Ohta, K.; Schermer, T.; Valovirta, E.; Zhong, N.; Zuberbier, T. Allergic rhinitis management pocket reference. Allergy, 2008, 63, 990-6.
72. Shaaban, R.; Zureik, M.; Soussan, D.; Neukirch, C.; Heinrich, J.; Sunyer, J.; Wjst, M.; Cerveri, I.; Pin, I.; Bousquet, J.; Jarvis, D.; Burney, P.G.; Neukirch, F.; Leynaert, B. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet, 2008, 372, 1049-57.
73. Rogers, D.F. Airway hypersecretion in allergic rhinitis and asthma: new pharmacotherapy. Curr. Allergy Asthma Rep., 2003, 3, 238-48.
74. Rogers, D.F.; Barnes, P.J. Treatment of airway mucus hypersecretion. Ann. Med., 2006, 38, 116-25.
75. Dejima, K.; Randell, S.H.; Stutts, M.J.; Senior, B.A.; Boucher, R.C. Potential role of abnormal ion transport in the pathogenesis of chronic sinusitis. Arch. Otolaryngol. Head Neck Surg., 2006, 132, 1352-62.
76. Yasuda, M.; Niisato, N.; Miyazaki, H.; Hama, T.; Dejima, K.; Hisa, Y.; Marunaka, Y. Epithelial ion transport of human nasal polyp and paranasal sinus mucosa. Am. J. Respir. Cell Mol. Biol., 2007, 36, 466-72.
77. Lee, S.H.; Park, J.H.; Jung, H.H.; Lee, S.H.; Oh, J.W.; Lee, H.M.; Jun, H.S.; Cho, W.J.; Lee, J.Y. Expression and distribution of ion transport mRNAs in human nasal mucosa and nasal polyps. Acta Otolaryngol., 2005, 125, 745-52.
78. Kim, Y.M.; Won, T.B.; Kim, S.W.; Min, Y.G.; Lee, C.H.; Rhee, C.S. Histamine induces MUC5AC expression via a hCLCA1 pathway. Pharmacology, 2007, 80, 219-26.
79. Li, H.; Jiang, H.; Cheng, L.; Oh, Y.; Xu, G. Possible role of transforming growth factor beta and interleukin-4 in the up-regulation of CLC-2 and CLC-3 in chronic rhinosinusitis. Am. J. Rhinol., 2007, 21, 389-94.
80. Li, H.; Wen, W.; Cheng, L.; Shi, J.; Jiang, H.; Oh, Y.; Xu, G. Expression of chloride channel protein CLC-3 in patients with allergic rhinitis: effect of topical corticosteroid treatment. Arch. Otolaryngol. Head Neck Surg., 2008, 134, 301-5.
81. Hauber, H.P.; Manoukian, J.J.; Nguyen, L.H.; Sobol, S.E.; Levitt, R.C.; Holroyd, K.J.; McElvaney, N.G.; Griffin, S.; Hamid, Q. Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Laryngoscope, 2003, 113, 1037-42.
82. Hauber, H.P.; Tsicopoulos, A.; Wallaert, B.; Griffin, S.; McElvaney, N.G.; Daigneault, P.; Mueller, Z.; Olivenstein, R.; Holroyd, K.J.; Levitt, R.C.; Hamid, Q. Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction. Eur. Respir. J., 2004, 23, 846-50.
83. Young, F.D.; Newbigging, S.; Choi, C.; Keet, M.; Kent, G.; Rozmahel, R.F. Amelioration of cystic fibrosis intestinal mucous disease in mice by restoration of mCLCA3. Gastroenterology, 2007, 133, 1928-37.
84. Kamada, F.; Suzuki, Y.; Shao, C.; Tamari, M.; Hasegawa, K.; Hirota, T.; Shimizu, M.; Takahashi, N.; Mao, X.Q.; Doi, S.; Fujiwara, H.; Miyatake, A.; Fujita, K.; Chiba, Y.; Aoki, Y.; Kure, S.; Tamura, G.; Shirakawa, T.; Matsubara, Y. Association of the hCLCA1 gene with childhood and adult asthma. Genes Immun., 2004, 5, 540-7.
85. Woodruff, P.G.; Boushey, H.A.; Dolganov, G.M.; Barker, C.S.; Yang, Y. H.; Donnelly, S.; Ellwanger, A.; Sidhu, S.S.; Dao-Pick, T.P.; Pantoja, C.; Erle, D.J.; Yamamoto, K.R.; Fahy, J.V. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA, 2007, 104, 15858-63.
86. Knight, D., Talniflumate (Genaera). Curr. Opin. Investig. Drugs, 2004, 5, 557-62.
87. Hauber, H.P.; Daigneault, P.; Frenkiel, S.; Lavigne, F.; Hung, H.L.; Levitt, R. C.; Hamid, Q. Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J. Allergy Clin. Immunol., 2005, 115, 266-71.
88. Nakano, T.; Inoue, H.; Fukuyama, S.; Matsumoto, K.; Matsumura, M.; Tsuda, M.; Matsumoto, T.; Aizawa, H.; Nakanishi, Y. Niflumic acid suppresses interleukin-13-induced asthma phenotypes. Am. J. Respir. Crit. Care Med., 2006, 173, 1216-21.
89. Bertrand, C.A.; Danahay, H.; Poll, C.T.; Laboisse, C.; Hopfer, U.; Bridges, R.J. Niflumic acid inhibits ATP-stimulated exocytosis in a mucin-secreting epithelial cell line. Am. J. Physiol. Cell Physiol., 2004, 286, C247-55.
90. Veronesi, P.A. KR900000869B, 1990.
91. Yu, C.; Xu, L. WO2008029199, 2008.
92. Iwashita, H.; Morita, S.; Shimakawa, K. JP2005130748, 2005.
93. Nakanishi, A.; Iwashita, H.; Morita, S. WO2004005495, 2004.
94. Long, A.J.; Wood, C.R.; Bowman, M. US20042655314, 2006.
95. Long, A.J.; Wood, C.R.; Bowman, M.; Goldman, S.J.; Sypek, J.P. WO2004105793, 2004.
96. 2+-activated chloride channel from human corneal epithelium. Curr. Eye Res., 2000, 21, 918-25.